| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_050fc7b82c5d17d9aeb63a7cdcc546b3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-306 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-28 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-28 |
| filingDate |
2017-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a01338412aa50ffe7fcb097cbe6f7114
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb66c45abf2e2d4c97a9ea50b85fbc7e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49f7363a748d1f39ad87da06fece8972
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_045697b2578b21feaa350b27125d0379
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b066af1f25bd9b686340799295943d30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8384e8ef102ce5d3aee264575847d15 |
| publicationDate |
2019-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20190043413-A |
| titleOfInvention |
A composition comprising chick bone marrow derived osteochondroprogenitor cell culture as an active ingredient for promoting osteogenesis |
| abstract |
TECHNICAL FIELD The present invention relates to a composition for promoting bone formation, and more particularly to a composition for promoting osteogenesis including a bone marrow-derived bone / cartilage precursor cell culture fluid as an effective ingredient. According to the present invention, when a bone marrow-derived bone / chondrocyte precursor cell culture medium is mixed with a chemical-based differentiation inducer used for inducing bone cells according to the present invention, stem cells are more effectively used than bone- Can be differentiated into bone cells. Accordingly, the present invention is not limited to a therapeutic agent or an adjuvant for osteoporosis diseases that require new bone formation or regeneration such as osteoporosis, bone defect disease, Paget's disease, osteonecrosis of femoral head and osteoarthritis, . |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023018244-A1 |
| priorityDate |
2017-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |